News
Inside Biotech: Lumonus links with top global cancer centre to sharpen AI-driven radiation planning
2+ hour, 29+ min ago (454+ words) Radiation therapy remains one of the most widely used cancer treatments, but the process of planning each patient's treatment is still complex, time-intensive and heavily dependent on specialist input. Lumonus is focused on making that process more consistent and less…...
Why Anti-Cancer Drugs Often Fall Short of Expectations
2+ hour, 48+ min ago (1014+ words) In the relentless pursuit of effective cancer therapies, a class of molecules known as BET inhibitors has captured significant scientific attention for over a decade. These inhibitors were heralded as a promising breakthrough due to their ability to block BET…...
Future Perspectives: Key Trends Shaping the B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Until 2030
3+ hour ago (56+ words) open PR. com We are establishing a secure connection. This website is using a security service to protect itself from online attacks. We are checking your browser to establish a secure connection and keep you safe. Performance & security by bunny....
Cortisol-resistant CAR-NK cells overcome steroid-induced immunosuppression in lung cancer - Signal Transduction and Targeted Therapy
6+ hour, 39+ min ago (1673+ words) Cortisol response score, hypoxia response score, NK dysfunctional score, and NK effector score have been calculated using Seurat's Add Module Score function, using the cortisol-responsive gene list as the input feature set. NKG2 A (KLRC1), KIR2 DL3, TIGIT, HAVCR2 (TIM3), PDCD1 (PD-1), LAG3, KLRG1, TIM3 PDCD1, CTLA4, LAG3, HAVCR2, TIGIT, BTLA, CD244, CD160, KLRG1, C10orf54 (VISTA), TOX, TOX2, NR4 A1, NR4 A2, BATF,…...
RNA Alone Doesn't Tell the Full Immune Story
13+ hour, 10+ min ago (693+ words) Our immune system is constantly making decisions. Immune cells sense danger, send signals, call for backup and sometimes attack. Scientists have long studied these decisions by reading RNA. But RNA doesn't always tell the full story. The study was led…...
Pre-made particles could enable 4-week pandemic vaccine response
6+ hour, 25+ min ago (468+ words) James Swartz, formerly of Genentech, a Roche subsidiary, speaks at the KSBB International Symposium It took about a year for the COVID-19 vaccine to become available. Professor James Swartz of Stanford University's Department of Chemical and Bioengineering says, "We can…...
Synthetic Super-Enhancers Power Targeted Viral Immunotherapy
4+ hour, 59+ min ago (1267+ words) Bioengineer. org In a groundbreaking study published in Nature, researchers have unveiled the remarkable potential of synthetic super-enhancers (SSEs) to revolutionize precision viral immunotherapy. This cutting-edge work brilliantly bridges developmental biology and therapeutic innovation by harnessing the evolutionary conservation and…...
TAE Life Sciences Announces Breakthrough BNCT Research Demonstrating Durable Tumor Control and Systemic Immune Effects
5+ hour, 6+ min ago (213+ words) FOOTHILL RANCH, Calif. --(BUSINESS WIRE)--TAE Life Sciences (TLS), a leader in Boron Neutron Capture Therapy (BNCT), today announced the publication of new research in ACS Pharmacology & Translational Science (an ACS journal), demonstrating that its next-generation boron delivery platform may…...
BREAKTHROUGH | Bacteria eats cancer tumors from within.
10+ hour, 35+ min ago (51+ words) The Greatest News Site On The Internet. Home of CFP Nation. Go To Article -- scitechdaily. com Posted by Kane on April 8, 2026 10: 35 pm NEWS JUNKIES -- CHECK OUT OUR HOMEPAGE...
First-in-class Dual HIF Inhibitors Eliminate Multiple Tumor Types in Mice when Combined with Immunotherapy - The Elm
14+ hour, 35+ min ago (160+ words) First-in-class Dual HIF Inhibitors Eliminate Multiple Tumor Types in Mice when Combined with Immunotherapy'The University of Maryland, Baltimore First-in-class Dual HIF Inhibitors Eliminate Multiple Tumor Types in Mice when Combined with Immunotherapy Researchers at the University of Maryland School of…...